May 18, 2020 / NTS GMT
Unidentified Analyst -
Good afternoon, everyone, and thank you for coming to the 2020 Virtual UBS Global Health Care Conference. My name is [Tay], and I'm happy to be your host for this session. Our next presenter will be Søren Tulstrup, President and CEO of Hansa Biopharma. Following the presentation, we will have a Q&A session. (Operator Instructions) As a reminder, all presentations will be limited to 40 minutes, including Q&A.
We now turn it over to Soren. Thank you.
Søren Tulstrup - Hansa Biopharma AB(publ)-President&CEO
Thank you, moderator, and good morning or good afternoon, everyone, and thank you for your interest in Hansa Biopharma.
Please turn to Slide 2. Before I start, I just want to point to the fact that this presentation contains forward-looking statements. And as such, you should apply the usual caution.
Now please turn to Slide 3, a high-level overview of Hansa Biopharma. So Hansa Biopharma was founded back in 2007 as a spinout from Lund
Hansa Biopharma AB at UBS Global Healthcare Conference (Virtual) Transcript
May 18, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers